a
Mark Miedema, MD, of Little Rock-based OrthoArkansas, is using stem cells to help arthritis sufferers, according to KATV.
The global tissue engineering market is set to grow at a compound annual growth rate of 17.22 percent through 2022, according to a Market Research Future report.
The Europe regenerative medicines market is set to grow at a 21.8 percent compound annual growth rate through 2021, based on a Market Data Forecast, according to medGadget.

4. MiMedx cautions CEO imposter emails: 5 things to know

Written by Mackenzie Garrity | Tuesday, 17 October 2017 20:22
MiMedx Group launched an investigation into fake email accounts impersonating the company's CEO and other executives.
DSM Biomedical partnered with Cerapedics, a privately held orthobiologics company, to develop a next generation peptide enhanced bone graft.
Stem Cell Center Network plans to open a new practice in West Palm Beach, Fla. This will be the network's 5th U.S. facility.
Mick Perez-Cruet, MD, is the chief of minimally invasive spine surgery at Beaumont Hospitals in Royal Oak, Mich., and a neurosurgeon at Michigan Head & Spine Institute in Southfield. He also serves as chairman, director and professor of minimally invasive spine surgery at Oakland University William Beaumont School of Medicine and leads the Minimally Invasive Neurological Society.
The FDA will allow DiscGenics to conduct an investigational new drug study of IDCT.
Asterias Biotherapeutics reported 12-month data for its Phase 1/2a SCiStar study on spinal cord injury treatment.
Nashville-based Tennessee Orthopaedic Alliance is leveraging platelet rich plasma to treat orthopedic injuries.
James Andrews, MD, and his team at Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics and Sports Medicine are turning to stem cells as the next frontier in sports injury treatments, according to Sports Illustrated.
The global orthobiologics market is predicted to reach $6.06 billion by 2022, growing at a compounded annual rate of 5.4 percent.

13. DiscGenics earns $14M in Series B financing round — 5 points

Written by Megan Wood | Tuesday, 26 September 2017 17:44
DiscGenics closed a Series B financing round.
Columbia-based University of Missouri School of Medicine researchers studied bone marrow aspirate concentrate's impact on knee joint transplant outcomes.

15. Spine biologics market to make it big in the near future

Written by Ehtesham Peerzade | Wednesday, 20 September 2017 16:15
The surgery of spines has begun in the late 1800s. It was not systematic until around 1916 when the neurosurgeon Dr. Charles Elsberg published a book mentioning how to perform surgical procedures on the spine and spinal cord for various conditions.
The FDA issued a warning letter to the Sunrise, Fla.-based US Stem Cell Clinic for inaccurate marketing of its stem cell products as well as other deviations, according to the FDA.
Bone Biologics Corp. reported the addition of osteoporosis and trauma indications to its portfolio.
  The global spine biologics market is predicted to exceed more than $2.5 billion by 2022 with a growth rate of 4.4 percent, Finance Wire reports.
Four spine surgeons discuss trends in the use of spine biologics.
The global spine biologics market will grow through 2024, based on a Transparency Market Research report, according to medGadget.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 50